NTDT Iron Burden: Assessment of cumulative hyperabsorption. Ferritin in NTDT underestimates risk compared to TDT equivalents.
Threshold for chelation: 800
Threshold for chelation: 5.0
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Assess
All patients with Non-Transfusion-Dependent Thalassaemia (NTDT) aged ≥ 10 years.
Monitoring for cumulative iron absorption from the GI tract (even without transfusion).
Predicting risk of iron-related end-organ damage (liver, endocrine, heart).
NTDT Paradox
In NTDT, serum Ferritin systematically underestimates the total body iron burden compared to TDT. A ferritin of 800 in NTDT may reflect the same liver iron as a ferritin of 2500 in TDT.
Section 2
Formula & Logic
Biomarker Thresholds
Parameter
Threshold for Chelation
Goal / Stop
Serum Ferritin
≥ 800 ng/mL
< 300 ng/mL
Liver Iron (LIC)
≥ 5 mg Fe/g dw
< 3 mg Fe/g dw
Monitoring Frequency
Serum Ferritin: Every 3 months.
LIC (via MRI R2*): Every 12 months.
Section 3
Pearls/Pitfalls
Why LIC > Ferritin?
In NTDT, iron is absorbed slowly via the gut and distributed primarily to hepatocytes. Ferritin, which is partially driven by macrophage iron, remains lower because the reticuloendothelial system is relatively spared compared to transfusion-based overload.
Section 4
Evidence Appraisal
Primary Consensus
Guidelines for the management of non-transfusion-dependent thalassaemia (NTDT).
Taher AT et al. • TIF Publications. 2017;2nd Edition.
The understanding of NTDT as a distinct clinical entity with its own iron dynamics emerged in the early 2010s, leading to the THALASSA trial and refined TIF guidelines.